<bill session="115" type="h" number="5725" updated="2023-01-11T13:39:34Z">
  <state datetime="2018-05-09">REFERRED</state>
  <status>
    <introduced datetime="2018-05-09"/>
  </status>
  <introduced datetime="2018-05-09"/>
  <titles>
    <title type="display">BEST Act</title>
    <title type="official" as="introduced">To direct the Secretary of Health and Human Services to submit to Congress a report on the extent to which Medicare Advantage plans offered under part C of the Medicare program include supplemental health care benefits designed to treat or prevent substance use disorders.</title>
    <title type="short" as="introduced">Benefit Evaluation of Safe Treatment Act of 2018</title>
    <title type="short" as="introduced">BEST Act</title>
  </titles>
  <sponsor bioguide_id="R000580"/>
  <cosponsors>
    <cosponsor bioguide_id="R000599" joined="2018-05-09"/>
    <cosponsor bioguide_id="S000364" joined="2018-05-09"/>
    <cosponsor bioguide_id="S001156" joined="2018-05-09"/>
  </cosponsors>
  <actions>
    <action datetime="2018-05-09">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-05-09" state="REFERRED">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-09">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2018-05-23">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="115" type="h" number="6110" relation="unknown"/>
    <bill session="115" type="h" number="6" relation="unknown"/>
    <bill session="115" type="h" number="5776" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Government studies and investigations"/>
    <term name="Health care coverage and access"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2018-09-11T19:28:06Z" status="Introduced in House">Benefit Evaluation of Safe Treatment Act of 2018 or the BEST Act of 2018

This bill requires the Centers for Medicare &amp; Medicaid Services to report on the availability of supplemental health care benefits for the prevention and treatment of substance use disorders under Medicare Advantage (MA) plans, including differences between MA plans for certain individuals with special needs and other MA plans.</summary>
</bill>
